News
Donald Trump and his administration have waged an all-out assault on America's founding principles over the president's first 100 days in office.
DMX-200 is a small molecule inhibitor of the chemokine receptor 2 (CCR2). The ACTION3 trial is a randomised, double-blind, placebo-controlled study of the efficacy and safety of DMX-200 in patients ...
1h
Stockhead on MSNASX Health Quarterly Wrap: Island completes Phase 2a/b dengue trialIsland Pharmaeuticals, Dimerix and Tryptamine Therapeutics are among ASX health stocks reporting quarterly results this week.
10h
Stockhead on MSNASX Quarterly Health Wrap: Control Bionics reports strong US revenue, LTR Pharma makes progress with FDAControl Bionics, LTR Pharma and Lumos Diagnostics are among ASX health companies reporting strong quarterly results this week ...
15hon MSN
This is a photo collection curated by AP photo editors.
23m
AAP Newsroom on MSN'Perfect storm' as ADHD medications in short supplyOne million Australians could be forced to fork out more for medicines used to treat ADHD as widespread shortages could last ...
Peter Dutton, who seeks to become Australia's prime minister in Saturday's national election, is known as a plain-speaking conservative who has attracted suburban voters with tough crime and border ...
The goal of the RFI is to learn about existing technologies that can capture facial images of all travelers in ...
In October 2017, a couple created a GoFundMe page for a homeless veteran and concocted a heartwarming, but false story that ...
How would you feel if five government agents suddenly surrounded your car and said they were going to search it?
As Donald Trump marks his first 100 days back in the White House, a leading travel expert has warned that his early policy decisions particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results